Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2013
Title: Tove Ringerike: Innovator in Immunotoxicity Research
Introduction
Tove Ringerike is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of immunotoxicity through her innovative research and patented methods. Her work focuses on characterizing the immunotoxic activity of xenobiotic substances, which is crucial for understanding their potential effects on human health.
Latest Patents
Tove Ringerike holds one patent titled "Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances." This patent describes a method for characterizing tested substances, particularly useful in studying their toxicity, with a specific emphasis on immunotoxicity. The patent also outlines cell lines and nucleic acids that can be utilized in this method, especially for obtaining cell-chip collections intended for immunotoxicity assays.
Career Highlights
Throughout her career, Tove has worked with several esteemed organizations, including the National Institute of Public Health and the Environment, the Laboratory for Pathology and Immunobiology, and the Norwegian Institute of Public Health, Division of Environmental Medicine. Her experience in these institutions has allowed her to develop her expertise in immunotoxicity and related fields.
Collaborations
Tove Ringerike has collaborated with notable colleagues such as Robert Jan Vandehriel and Aurelia Walczak-Drzewiecka. These collaborations have further enriched her research and contributed to advancements in the understanding of immunotoxicity.
Conclusion
Tove Ringerike's innovative work in immunotoxicity research and her patented methods highlight her significant contributions to the field. Her dedication to understanding the effects of xenobiotic substances on human health continues to inspire future research and innovation.